Company Win Pharm Group Srl with Fiscal Code 17407964
recorded a turnover of 2024 of
- ,
with a net profit of
-2.291
and having an average number of employees of
- .
The company operates in the field of Lucrari de constructii a cladirilor rezidentiale si nerezidentiale having the NACE code 4120.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Win Pharm Group Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
910.811
1.202.249
257.251
393.081
1.501.976
971.716
779.942
4.446
0
0
Total Income - EUR
1.585.727
1.202.249
444.217
1.390.366
914.230
675.429
219.738
4.964
168
1.351
Total Expenses - EUR
1.744.101
940.709
564.913
1.459.927
947.704
440.741
241.998
19.550
3.833
3.642
Gross Profit/Loss - EUR
-158.374
261.540
-120.695
-69.561
-33.474
234.688
-22.260
-14.585
-3.665
-2.291
Net Profit/Loss - EUR
-158.374
261.540
-120.695
-70.617
-33.474
212.099
-24.977
-14.585
-3.665
-2.291
Employees
8
8
10
5
0
3
1
0
0
0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Check the financial reports for the company - Win Pharm Group Srl
Financial Rating - WIN PHARM GROUP SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Win Pharm Group Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Win Pharm Group Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Win Pharm Group Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Win Pharm Group Srl - CUI 17407964
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
98.367
92.111
724.485
16.267
16.768
137.766
2.659
829
477
379
Current Assets
795.911
84.657
348.185
2.354.448
1.456.242
677.238
98.212
71.101
71.681
71.665
Inventories
0
0
196.651
1.834.929
1.058.418
459.636
0
0
0
0
Receivables
791.251
79.145
100.737
477.071
286.403
170.418
75.176
71.045
71.498
70.808
Cash
4.660
5.512
50.798
42.448
111.422
47.184
23.036
56
183
857
Shareholders Funds
-650.477
-382.304
-496.530
-551.051
-595.911
-372.516
-35.468
-50.163
-53.676
-52.936
Social Capital
2.812
2.783
2.736
9.670
9.483
9.303
362.861
363.987
362.883
360.855
Debts
1.544.755
561.767
1.564.437
2.916.913
2.063.351
1.183.446
136.514
122.164
125.904
125.050
Income in Advance
0
6.609
6.441
5.502
5.794
4.936
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4120 - 4120"
CAEN Financial Year
4120
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
71.665 euro in 2024 which includes Inventories of
0 euro, Receivables of
70.808 euro and cash availability of
857 euro.
The company's Equity was valued at
-52.936 euro, while total Liabilities amounted to
125.050 euro.
Equity increased by 440 euro, from -53.676 euro in 2023, to -52.936 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Win Pharm Group Srl